<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>European Journal of Neurology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'European Journal of Neurology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=European+Journal+of+Neurology&t=European+Journal+of+Neurology&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 20:43:06 +0100</lastBuildDate>
        <item>
            <title>Subjective cognitive complaints: not to be dismissed</title>
            <link>http://www.medworm.com/index.php?rid=5668644&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03632.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668644</comments>
            <pubDate>Mon, 06 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5668644</guid>        </item>
        <item>
            <title>Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5668643&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03644.x</link>
            <description>Conclusions:  Our results provide useful information that the NURR1 and PITX3 gene expression is decreased in the PBL of Chinese patients with PD, indicating their possible systemic involvement in PD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668643</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5668643</guid>        </item>
        <item>
            <title>Somatic neuropathy is an independent predictor of all‐ and diabetes‐related mortality in type 2 diabetic patients: a population‐based 5‐year follow‐up study (KCIS No. 29)</title>
            <link>http://www.medworm.com/index.php?rid=5649967&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03659.x</link>
            <description>Conclusions:  Diabetic polyneuropathy was an independent predictor for all‐cause and diabetes‐related mortality. The presence of neuropathy together with other significant prognostic factors is informative to predict all‐cause death and death from diabetes‐related disease for patients diagnosed as type 2 diabetes. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649967</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649967</guid>        </item>
        <item>
            <title>Relationship of initial glucose level and all‐cause death in patients with ischaemic stroke: the roles of diabetes mellitus and glycated hemoglobin level</title>
            <link>http://www.medworm.com/index.php?rid=5649975&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03647.x</link>
            <description>Conclusions:  A significant association was confirmed between initial glucose level and mortality in non‐diabetic ischaemic stroke patients. The possible relationship between initial glucose level, HbA1c level, and mortality amongst ischaemic stroke patients with diabetes warrants further research. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649975</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649975</guid>        </item>
        <item>
            <title>Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response</title>
            <link>http://www.medworm.com/index.php?rid=5649974&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03648.x</link>
            <description>Conclusions:  In patients with RRMS who have a poor response, switch to another DMD may reduce the clinical activity of the disease. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649974</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649974</guid>        </item>
        <item>
            <title>Treatment for dystonia in childhood</title>
            <link>http://www.medworm.com/index.php?rid=5649973&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03649.x</link>
            <description>Management of childhood dystonia differs in certain respects from that of adult dystonia: (i) childhood dystonia is more often secondary than primary; (ii) mixed motor disorders are frequent; (iii) in children, the course of dystonia may be influenced by ongoing brain maturation and by the remarkable plasticity of the young brain; (iv) drug tolerability and effectiveness can be different in children; (v) the therapeutic strategy must be discussed with both the patient and his or her parents; and (vi) the child’s education must be taken into account. Based on a systematic review of the literature through June 2011 and on our personal experience, we propose a therapeutic approach to childhood dystonia. After a detailed clinical evaluation and a comprehensive work‐up to rule out a treatab...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649973</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649973</guid>        </item>
        <item>
            <title>Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen‐DRB1*15</title>
            <link>http://www.medworm.com/index.php?rid=5649972&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03650.x</link>
            <description>Conclusions:  UVR and vitamin D seem to affect MS risk in adults independently of HLA‐DRB1*15 status. UVR exposure may also exert a protective effect against developing MS via other pathways than those involving vitamin D. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649972</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649972</guid>        </item>
        <item>
            <title>Meningoencephaloradiculomyelitis after tick‐borne encephalitis virus infection: a case series</title>
            <link>http://www.medworm.com/index.php?rid=5649971&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03651.x</link>
            <description>Conclusions:  Polyradiculopathy and/or myelopathy as verified by electrophysiological examination within 4 weeks from symptom onset were indicative of a more severe disease course and a greater likelihood of moderate to serious sequelae even after long‐term rehabilitation. Older age at symptom onset seems to be associated with a less favourable outcome. Because of frequent long‐term hospitalization with immobilization and invasive ventilation, secondary complications, such as ventilation associated pulmonary infections and decubiti, must be avoided. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649971</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649971</guid>        </item>
        <item>
            <title>Low ankle–brachial index is a predictive factor for initial severity of acute ischaemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5649970&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03652.x</link>
            <description>Conclusions:  Patients with low ABI values presented with more severe ischaemic stroke. Contribution of pre‐existing PAD to leg weakness may play a role in the initial severity of stroke in patients with PAD. Our findings suggest that poor clinical outcomes in patients with PAD may be partially explained by their increased likelihood for severe stroke. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649970</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649970</guid>        </item>
        <item>
            <title>Neurodegeneration – Methods and Protocols</title>
            <link>http://www.medworm.com/index.php?rid=5649969&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03653.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649969</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649969</guid>        </item>
        <item>
            <title>Telomere length shortening in patients with dementia with Lewy bodies</title>
            <link>http://www.medworm.com/index.php?rid=5649968&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03655.x</link>
            <description>Conclusions:  These findings indicate that the etiopathology of DLB is considered to be an accelerated aging process. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649968</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649968</guid>        </item>
        <item>
            <title>Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5649976&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03658.x</link>
            <description>Conclusions:  These findings suggest that nigral iron deposition, correlating with decreased serum ceruloplasmin levels, is a risk factor in Parkinson’s disease across multiple motor phenotypic expressions. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649976</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649976</guid>        </item>
        <item>
            <title>Voxel‐based morphometry in patients with obsessive‐compulsive behaviors in behavioral variant frontotemporal dementia</title>
            <link>http://www.medworm.com/index.php?rid=5639460&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03656.x</link>
            <description>Conclusions:  Obsessive‐compulsive behaviors were frequent among these patients. The correlation with basal ganglia atrophy may point to involvement of frontal subcortical neuronal networks. Left lateral temporal lobe volume loss probably reflects the number of MAPT mutation patients included but also provides additional data implicating temporal lobe involvement in OC behaviors. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639460</comments>
            <pubDate>Mon, 30 Jan 2012 02:14:02 +0100</pubDate>
            <guid isPermaLink="false">5639460</guid>        </item>
        <item>
            <title>Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5610973&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03660.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5610973</comments>
            <pubDate>Sat, 21 Jan 2012 00:45:57 +0100</pubDate>
            <guid isPermaLink="false">5610973</guid>        </item>
        <item>
            <title>Mild traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=5610972&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03581.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5610972</comments>
            <pubDate>Sat, 21 Jan 2012 00:45:17 +0100</pubDate>
            <guid isPermaLink="false">5610972</guid>        </item>
        <item>
            <title>Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5599268&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03616.x</link>
            <description>Conclusions:  We have provided evidence that not all spread in ALS is contiguous and that the nature of symptom progression influences survival. Patients with sALS with ‘interposed patterns’ had a worse prognosis, whereas patients with caudo‐rostral pattern fared better than the rest. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599268</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599268</guid>        </item>
        <item>
            <title>Surgical therapy for multiple sclerosis tremor: a 12‐year follow‐up study</title>
            <link>http://www.medworm.com/index.php?rid=5599267&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03626.x</link>
            <description>Conclusions:  Surgery benefit for severe tremor was overall short‐lived (median 3 months), with long‐term poor prognosis. Although two DBS patients had sustained 5‐year tremor‐suppression, the observed progressive disability and death in this cohort bear importance for long‐term success in future MS tremor surgery trials. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599267</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599267</guid>        </item>
        <item>
            <title>Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia‐eclampsia and other predisposing diseases</title>
            <link>http://www.medworm.com/index.php?rid=5599266&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03629.x</link>
            <description>Conclusion:  In our PRES cohort, we found major clinicoradiological differences between preeclampsia‐eclampsia and other predisposing causes pointing toward a less severe course of disease in preeclampsia‐eclampsia. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599266</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599266</guid>        </item>
        <item>
            <title>Duodenal levodopa/carbidopa infusion therapy in patients with advanced Parkinson’s disease leads to improvement in caregivers’ stress and burden</title>
            <link>http://www.medworm.com/index.php?rid=5599265&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03630.x</link>
            <description>Conclusions:  Duodenal levodopa infusion‐related clinical improvement in patients with advanced PD leads to substantial reductions in caregivers’ stress and burden. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599265</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599265</guid>        </item>
        <item>
            <title>Is there a future for neuroprotective agents in acute ischaemic stroke?</title>
            <link>http://www.medworm.com/index.php?rid=5599264&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03633.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599264</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599264</guid>        </item>
        <item>
            <title>Magnetic resonance imaging abnormalities in children with epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=5599263&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03640.x</link>
            <description>Conclusions:  The use of MRI and a reliable standardized scoring system at diagnosis of epilepsy in children identified a high rate of significant abnormalities findings. This may have important implications for practice guidelines in this population. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599263</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599263</guid>        </item>
        <item>
            <title>Epilepsy associated with glutamic acid decarboxylase antibody (GADA)</title>
            <link>http://www.medworm.com/index.php?rid=5599262&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03641.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599262</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599262</guid>        </item>
        <item>
            <title>Animal Models of Movement Disorders: Volume I &amp; II</title>
            <link>http://www.medworm.com/index.php?rid=5599261&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03642.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599261</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599261</guid>        </item>
        <item>
            <title>Treatment for Helicobacter pylori infection and risk of parkinson’s disease in Denmark</title>
            <link>http://www.medworm.com/index.php?rid=5599260&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03643.x</link>
            <description>Conclusions:  Our population‐based study suggests that chronic HP infections and/or gastritis contribute to PD or that these are PD‐related pathologies that precede motor symptoms. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599260</comments>
            <pubDate>Tue, 17 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599260</guid>        </item>
        <item>
            <title>Ginsenoside‐Rd improves outcome of acute ischaemic stroke – a randomized, double‐blind, placebo‐controlled, multicenter trial</title>
            <link>http://www.medworm.com/index.php?rid=5599275&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03634.x</link>
            <description>Conclusions:  Ginsenoside‐Rd improved the primary outcome of acute ischaemic stroke and had an acceptable adverse‐event profile. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599275</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599275</guid>        </item>
        <item>
            <title>How subjective are subjective language complaints</title>
            <link>http://www.medworm.com/index.php?rid=5599274&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03635.x</link>
            <description>Conclusions:  Subjective language complaints are especially common amongst individuals living alone and/or with depressive symptoms. They are associated with a worse cognitive performance in some memory and language‐executive tests. Further studies are needed to understand their predictive value for cognitive decline. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599274</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599274</guid>        </item>
        <item>
            <title>Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5599273&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03637.x</link>
            <description>Conclusion:  In this study, we demonstrated that fatigue, a troublesome and disabling symptom in ALS, is associated with physical impairment and night‐time complaints (such as nocturia and muscle cramps), suggesting that treating sleep problems might be useful in alleviating fatigue in these patients. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599273</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599273</guid>        </item>
        <item>
            <title>Health‐related quality of life and depressive symptoms in significant others of people with multiple sclerosis: a community study</title>
            <link>http://www.medworm.com/index.php?rid=5599272&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03638.x</link>
            <description>Conclusions:  SOs had significantly lower vitality and psychological well‐being than controls, identifying a burden in being the companion of a person with MS. This burden was unrelated to physical compromise but associated with depressive symptoms in MS. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599272</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599272</guid>        </item>
        <item>
            <title>Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population</title>
            <link>http://www.medworm.com/index.php?rid=5599271&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03639.x</link>
            <description>Conclusions:  Our data suggest that the PRKN gene mutation is the most frequent form of ARPD in Turkey. The proportion of mutations with regard to the age of onset in our population is in the range of those previously described, but our pedigrees are characterized by high rate of consanguinity, which might explain the high proportion of families with homozygous mutations and of patients in more than one generation. Pathogenic DJ1 mutations do not seem to play a major role in Turkey. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599271</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599271</guid>        </item>
        <item>
            <title>Evidence for epistatic gene interactions between growth factor genes in stroke outcome</title>
            <link>http://www.medworm.com/index.php?rid=5599270&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03625.x</link>
            <description>Conclusions:  The results provide evidence for gene interactions in stroke outcome, highlighting the complexity of the recovery mechanisms after a stroke event. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599270</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599270</guid>        </item>
        <item>
            <title>CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5599269&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03646.x</link>
            <description>Conclusions:  Our findings do not support a role of the AR CAG repeat length in ALS. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599269</comments>
            <pubDate>Tue, 10 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599269</guid>        </item>
        <item>
            <title>Risk of extrathymic cancer in patients with myasthenia gravis in Taiwan: a nationwide population‐based study</title>
            <link>http://www.medworm.com/index.php?rid=5561938&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03621.x</link>
            <description>Conclusions:  Our study showed that patients with MG had an increased risk of extrathymic malignancy in a follow‐up of 8 years, but no specific susceptibility to certain malignancies was found. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561938</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561938</guid>        </item>
        <item>
            <title>Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5561937&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03593.x</link>
            <description>Motor fluctuations and motor complications are a major consequence of the treatment and progression of Parkinson’s disease (PD) and they have, in particular, been linked to l‐dopa therapy. Using continuous dopaminergic stimulation (CDS) by employing longer acting dopaminergic drugs has been proposed as a means of avoiding or lowering their occurrence. However, both the preclinical and clinical evidence base suggest that this concept does not fully explain the differences between l‐dopa and dopamine (DA) agonist drugs and that their pharmacological profiles may also be important. In addition, the way in which drugs are delivered in PD appears to have a marked influence on both efficacy and side‐effect profile. As a consequence, the concept of continuous drug delivery (CDD) has arise...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561937</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561937</guid>        </item>
        <item>
            <title>Sex differences in perihemorrhagic edema evolution after spontaneous intracerebral hemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=5561936&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03628.x</link>
            <description>Conclusions:  Female sex may predict lower PHE volumes. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561936</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561936</guid>        </item>
        <item>
            <title>High anti‐EBNA‐1 IgG levels are associated with early‐onset myasthenia gravis</title>
            <link>http://www.medworm.com/index.php?rid=5561935&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03636.x</link>
            <description>Conclusions:  In summary, our data suggest that high levels of EBNA‐1 antibodies are more common in MG compared to healthy controls and are especially associated with EOMG. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561935</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561935</guid>        </item>
        <item>
            <title>Elevated levels of IFNγ and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5561934&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03623.x</link>
            <description>Conclusion:  These findings in sporadic ALS cases, which are consistent with the observation made in ALS experimental models, propose that the IFNγ‐triggered LIGHT/LT‐βR‐mediated death pathway may contribute to human ALS pathogenesis. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561934</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561934</guid>        </item>
        <item>
            <title>Susac syndrome: clinical characteristics and treatment in 29 new cases</title>
            <link>http://www.medworm.com/index.php?rid=5561933&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03627.x</link>
            <description>Conclusions:  Susac syndrome may be severe, disabling, and protracted in some patients. PLEX may be an adjunct or alternative therapy for patients who do not experience symptomatic improvement following steroid treatment. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561933</comments>
            <pubDate>Wed, 04 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561933</guid>        </item>
        <item>
            <title>Medial temporal lobe is vulnerable to vascular risk factors in men: a population‐based study</title>
            <link>http://www.medworm.com/index.php?rid=5599259&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03645.x</link>
            <description>Conclusions:  Aggregation of VRFs is associated with reduced hippocampal and entorhinal cortex volume in apparently healthy elderly men, but not in women. This implies that in men, the medial temporal lobe is vulnerable to cardiovascular risk factors. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5599259</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5599259</guid>        </item>
        <item>
            <title>Correlation between genetic polymorphisms and stroke recovery</title>
            <link>http://www.medworm.com/index.php?rid=5561932&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03615.x</link>
            <description>Conclusions:  Genetic factors, particularly the ApoE ε4 polymorphism, might contribute to variability in outcomes after stroke. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561932</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5561932</guid>        </item>
        <item>
            <title>Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity</title>
            <link>http://www.medworm.com/index.php?rid=5545587&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03618.x</link>
            <description>Conclusions:  These findings show that BoNT/A injected into the detrusor muscle in patients with PD and SCI modulates bladder afferent activity. Modulation of bladder afferents possibly explains why BoNT/A improves detrusor overactivity. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5545587</comments>
            <pubDate>Wed, 28 Dec 2011 17:05:41 +0100</pubDate>
            <guid isPermaLink="false">5545587</guid>        </item>
        <item>
            <title>Cerebral artery calcification in patients with acute cerebrovascular diseases: determinants and long‐term clinical outcome</title>
            <link>http://www.medworm.com/index.php?rid=5539183&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03620.x</link>
            <description>Conclusions:  Intracranial CAC is highly prevalent in patients with acute stroke and its main determinants are older age, diabetes, smoking, hypertension, and prior coronary heart disease. Associations between CAC and mortality or poor functional outcome in the first year after ischaemic stroke are mainly age‐ and stroke severity‐driven. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539183</comments>
            <pubDate>Sun, 25 Dec 2011 13:14:42 +0100</pubDate>
            <guid isPermaLink="false">5539183</guid>        </item>
        <item>
            <title>Instructions for Authors</title>
            <link>http://www.medworm.com/index.php?rid=5516297&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03654.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516297</comments>
            <pubDate>Mon, 19 Dec 2011 13:07:53 +0100</pubDate>
            <guid isPermaLink="false">5516297</guid>        </item>
        <item>
            <title>Atypical hereditary spastic paraplegia with thin corpus callosum in a Korean patient with a novel SPG11 mutation</title>
            <link>http://www.medworm.com/index.php?rid=5516296&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03569.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516296</comments>
            <pubDate>Mon, 19 Dec 2011 13:07:49 +0100</pubDate>
            <guid isPermaLink="false">5516296</guid>        </item>
        <item>
            <title>Peripheral microcirculation dysfunction evaluated by computed tomography perfusion study in Fabry patients</title>
            <link>http://www.medworm.com/index.php?rid=5516295&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03558.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516295</comments>
            <pubDate>Mon, 19 Dec 2011 13:07:47 +0100</pubDate>
            <guid isPermaLink="false">5516295</guid>        </item>
        <item>
            <title>Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5516294&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03631.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516294</comments>
            <pubDate>Mon, 19 Dec 2011 13:07:46 +0100</pubDate>
            <guid isPermaLink="false">5516294</guid>        </item>
        <item>
            <title>The economic cost of brain disorders in Europe</title>
            <link>http://www.medworm.com/index.php?rid=5516293&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03590.x</link>
            <description>Conclusion:  Our cost model revealed that brain disorders overall are much more costly than previously estimated constituting a major health economic challenge for Europe. Our estimate should be regarded as conservative because many disorders or cost items could not be included because of lack of data. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516293</comments>
            <pubDate>Mon, 19 Dec 2011 13:07:38 +0100</pubDate>
            <guid isPermaLink="false">5516293</guid>        </item>
        <item>
            <title>Depression after minor stroke: prevalence and predictors</title>
            <link>http://www.medworm.com/index.php?rid=5516290&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03583.x</link>
            <description>Conclusion:  Post‐stroke depression is frequent even in patients with minor stroke. Early detection of DSs might help to predict long‐term development of PSD. No correlation was observed between lesion site or side and the development of PSD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516290</comments>
            <pubDate>Mon, 19 Dec 2011 13:04:31 +0100</pubDate>
            <guid isPermaLink="false">5516290</guid>        </item>
        <item>
            <title>IV Valproate in generalized convulsive status epilepticus: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5539187&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03606.x</link>
            <description>Aim of this review was to evaluate efficacy and safety of intravenous valproate (IV VPA) in the treatment of generalized convulsive status epilepticus (GCSE) in patients of any age, synthesizing available evidences from randomized controlled trials (RCTs). RCTs on IV VPA administered in patients (no age restriction) for GCSE at any stage were searched in MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials. Studies were selected and data independently extracted. Following outcomes were considered: clinical seizure cessation after drug administration, seizure freedom at 24 h, and adverse effects. Outcomes were assessed using standard methods to calculate risk ratio (RR) with 95% confidence intervals. Five trials met inclusion criteria. Two different comparisons were availabl...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539187</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539187</guid>        </item>
        <item>
            <title>Narcolepsy and sleep‐disordered breathing</title>
            <link>http://www.medworm.com/index.php?rid=5539186&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03610.x</link>
            <description>Conclusion:  Coexisting SDB is common in narcoleptics (28.5%). CPAP therapy in narcoleptics with OSAHS remains a useful second‐line adjunct to standard therapy. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539186</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539186</guid>        </item>
        <item>
            <title>Anti‐N‐methyl‐d‐aspartate receptor encephalitis with acute disseminated encephalomyelitis‐like MRI features</title>
            <link>http://www.medworm.com/index.php?rid=5539185&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03617.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539185</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539185</guid>        </item>
        <item>
            <title>Predisposing factors of pituitary hemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=5539184&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03619.x</link>
            <description>Conclusions:  In this pooled cohort, the predisposing factors of pituitary adenoma characteristic for pituitary hemorrhage were macroadenoma and non‐functional adenoma. Patients who received dopamine agonist and anticoagulation therapy are implicated as precipitating factors. Underlying end‐stage renal disease and malignant disease are also factors that contribute to pituitary adenoma hemorrhage. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5539184</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5539184</guid>        </item>
        <item>
            <title>Effect of statin treatment on three‐month outcomes in patients with stroke‐associated infection: a prospective cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5516292&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03608.x</link>
            <description>Conclusions:  Statin use was not associated with a better functional outcome or survival in patients with stroke‐associated infection. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516292</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5516292</guid>        </item>
        <item>
            <title>Combined brain voxel‐based morphometry and diffusion tensor imaging study in idiopathic Restless Legs Syndrome patients</title>
            <link>http://www.medworm.com/index.php?rid=5516291&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03604.x</link>
            <description>Conclusions:  Our data argue against clear structural or microstructural abnormalities in the brain of patients with idiopathic RLS, suggesting a prevalent role of functional or metabolic impairment. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516291</comments>
            <pubDate>Mon, 19 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5516291</guid>        </item>
        <item>
            <title>Adverse life event and risk of cognitive impairment: a 5‐year prospective longitudinal study in Chongqing, China</title>
            <link>http://www.medworm.com/index.php?rid=5477935&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03599.x</link>
            <description>Conclusions:  Adverse life events, such as the death of a spouse and a financial crisis, are associated with a higher risk of cognitive impairment. Further in‐depth longitudinal and intervention studies are needed to confirm the causal relationship between adverse life events and risk of cognitive impairment in the future. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477935</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477935</guid>        </item>
        <item>
            <title>Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis</title>
            <link>http://www.medworm.com/index.php?rid=5477934&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03597.x</link>
            <description>Progressive multifocal leukoencephalopathy (PML) is an uncommon and often fatal demyelinating disease of human central nervous system, which is caused by reactivation of the polyomavirus JC (JCV). PML generally occurs in patients with profound immunosuppression such as AIDS patients. Recently, a number of PML cases have been associated with administration of natalizumab for treatment of multiple sclerosis (MS) patients. Diagnosis and management of PML became a major concern after its occurrence in multiple sclerosis patients treated with natalizumab. Diagnosis of PML usually rests on neuroimaging in the appropriate clinical context and is further confirmed by cerebrospinal fluid polymerase chain reaction (PCR) for JCV DNA. Treatment with antiretroviral therapies in HIV‐seropositive patie...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477934</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477934</guid>        </item>
        <item>
            <title>Dietary patterns and risk of Parkinson’s disease: a case–control study in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5477933&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03600.x</link>
            <description>Conclusion:  In this case–control study in Japan, a dietary pattern consisting of high intakes of vegetables, fruits and fish may be associated with a decreased risk of PD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477933</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477933</guid>        </item>
        <item>
            <title>Multiple sclerosis and cognitive dysfunction: how accurate are patients’ self‐assessments?</title>
            <link>http://www.medworm.com/index.php?rid=5477932&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03601.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477932</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477932</guid>        </item>
        <item>
            <title>Increased number of Purkinje cell dendritic swellings in essential tremor</title>
            <link>http://www.medworm.com/index.php?rid=5477931&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03598.x</link>
            <description>Conclusion:  The current study documents and quantifies an additional structural abnormality in the ET cerebellum, adding to the growing list of such changes in this disease. The mechanisms that underlie this and other structural changes observed in ET are currently unknown, and they deserve additional exploration. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477931</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477931</guid>        </item>
        <item>
            <title>The cost of headache disorders in Europe: the Eurolight project</title>
            <link>http://www.medworm.com/index.php?rid=5477930&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03612.x</link>
            <description>Conclusions:  Headache disorders are prominent health‐related drivers of immense economic losses for the EU. This has immediate implications for healthcare policy. Health care for headache can be both improved and cost saving. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477930</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477930</guid>        </item>
        <item>
            <title>Intestinal levodopa infusion and COMT inhibition – a promising link</title>
            <link>http://www.medworm.com/index.php?rid=5477929&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03611.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477929</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477929</guid>        </item>
        <item>
            <title>Dry beriberi mimicking Guillain–Barre syndrome as the first presenting sign of thiamine deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5477928&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03602.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477928</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477928</guid>        </item>
        <item>
            <title>Off‐hours admission for acute stroke is not associated with worse outcome – a nationwide Israeli stroke project</title>
            <link>http://www.medworm.com/index.php?rid=5477927&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03603.x</link>
            <description>Conclusions:  Off‐hours stroke admissions were associated with higher short‐term mortality rate, probably due to a higher rate of ICH. After controlling for the latter and other potential confounders, ‘off‐hours’ admissions were not different from ‘on‐hours’ with respect to poor outcome. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477927</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477927</guid>        </item>
        <item>
            <title>A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy</title>
            <link>http://www.medworm.com/index.php?rid=5477926&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03605.x</link>
            <description>Conclusion:  Cut‐offs for DCMAPD are dependent on EMG filter settings. DCMAPD prolongation in any motor nerve, using our derived cut‐offs, represents a sensitive and specific marker of CIDP in patients studied with EMG equipment with low‐cut filter settings ≤ 10 Hz. Appropriate use of this parameter appears an essential criterion to consider in assessing suspected CIDP, which may be helpful in limiting extensiveness and duration of electrophysiological testing, thereby reducing patient discomfort. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477926</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477926</guid>        </item>
        <item>
            <title>Serum cholesterol levels and survival after rtPA treatment in acute stroke</title>
            <link>http://www.medworm.com/index.php?rid=5477925&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03607.x</link>
            <description>Conclusions:  Survival of stroke patients receiving current, most effective medical treatment is related to blood cholesterol levels, with an inverse relationship between cholesterol and mortality. The mechanism of this apparently paradoxical situation remains unexplained but merits further research. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477925</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477925</guid>        </item>
        <item>
            <title>One‐year survival of demented stroke patients: data from the Dijon Stroke Registry, France (1985–2008)</title>
            <link>http://www.medworm.com/index.php?rid=5477924&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03613.x</link>
            <description>Conclusions:  Dementia after stroke is not independently associated with an increased risk of death at 1 year. In recent years, 1‐year case‐fatality decreased in demented as well as in and non‐demented patients suggesting that improvements in the management of stroke also benefited the most fragile patients. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477924</comments>
            <pubDate>Mon, 05 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477924</guid>        </item>
        <item>
            <title>Gender and cervical artery dissection</title>
            <link>http://www.medworm.com/index.php?rid=5488389&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03586.x</link>
            <description>Conclusion:  Our analysis of the largest collection of CeAD patients to date confirms male predominance and differences in age at dissection between men and women. Gender differences in putative risk factors may explain the higher frequency of CeAD in men and their older age, but the putative risk factors are probably not specific for CeAD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488389</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5488389</guid>        </item>
        <item>
            <title>Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial</title>
            <link>http://www.medworm.com/index.php?rid=5477923&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03614.x</link>
            <description>Conclusions:  According to this small, short‐term pilot study, oral catechol‐O‐methyltransferase inhibitors administered in 5‐h intervals may be useful in cases where levodopa/carbidopa intestinal gel dose reduction is wanted. Stability of plasma levodopa levels is not significantly altered, and off‐time is not increased when decreasing the levodopa/carbidopa intestinal gel dose by 20%. Rather, the dose should probably be decreased more than 20%, especially under tolcapone co‐treatment, to avoid increased dyskinesias with time. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477923</comments>
            <pubDate>Thu, 01 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5477923</guid>        </item>
        <item>
            <title>Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5442945&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03596.x</link>
            <description>Conclusion:  Consumption of alcoholic beverages, coffee and fish were inversely associated with progression of disability in relapsing onset MS, but not in progressive onset MS. These findings allow to support the hypothesis that different mechanisms might underlie progression of disability in relapsing and progressive onset MS. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442945</comments>
            <pubDate>Fri, 25 Nov 2011 13:13:24 +0100</pubDate>
            <guid isPermaLink="false">5442945</guid>        </item>
        <item>
            <title>Recurrent Miller Fisher syndrome: clinical and laboratory features</title>
            <link>http://www.medworm.com/index.php?rid=5442948&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03584.x</link>
            <description>To present two patients with Miller Fisher syndrome (MFS) recurrence after 35 and 44 years and review of the literature on recurring MFS. All identified cases with recurrent MFS were evaluated. Age, gender, clinical features of first and recurrent MFS, course of disease, laboratory findings, therapy and outcome were transformed into tables. Twenty‐eight patients (16 men, 12 women; mean age at the first episode 34 years (range 13–57 years); mean age at the latest episode 47 years (range 21–66 years) with a total of 70 MFS episodes were identified. Twenty‐one patients had a single recurrence, five patients had two recurrences, one patient had four recurrences and one patient had seven recurrences. The mean interval between attacks was 9.45 years (3 months to 44 years)...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442948</comments>
            <pubDate>Fri, 25 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5442948</guid>        </item>
        <item>
            <title>Good long‐term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer‐blinded study</title>
            <link>http://www.medworm.com/index.php?rid=5442947&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03591.x</link>
            <description>Conclusions:  This single‐blinded study shows good long‐term efficacy of GPi‐DBS in CD patients and supports using this treatment in those who have insufficient response to medical treatment. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442947</comments>
            <pubDate>Fri, 25 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5442947</guid>        </item>
        <item>
            <title>The self‐report Barthel Index: preliminary validation in people with Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5442946&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03592.x</link>
            <description>Conclusions:  Results suggest that the SRBI has the potential to be a reliable and valid indicator of ADL in PWP and utilized in studies that make comparisons across conditions. Further validation is required in a larger sample and through assessment of additional psychometric properties. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442946</comments>
            <pubDate>Fri, 25 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5442946</guid>        </item>
        <item>
            <title>Pantothenate kinase‐associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation</title>
            <link>http://www.medworm.com/index.php?rid=5432833&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03589.x</link>
            <description>Conclusions:  The c.1319G&amp;gt;C (p.R440P) mutation appears to be a founder genotype among Korean patients with PKAN. Furthermore, this study provides additional data for the recent international effort to evaluate the efficacy of pallidal DBS in the treatment of patients with PKAN. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432833</comments>
            <pubDate>Tue, 22 Nov 2011 13:09:07 +0100</pubDate>
            <guid isPermaLink="false">5432833</guid>        </item>
        <item>
            <title>A genotype–phenotype analysis of the 8q22.1 variant in migraine with aura</title>
            <link>http://www.medworm.com/index.php?rid=5432834&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03588.x</link>
            <description>Conclusion:  None of the clinical characteristics of MA were significantly influenced by the common susceptibility variant on 8q22.1. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432834</comments>
            <pubDate>Tue, 22 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5432834</guid>        </item>
        <item>
            <title>De novo P102L mutation in a patient with Gerstmann‐Sträussler‐Scheinker disease</title>
            <link>http://www.medworm.com/index.php?rid=5423684&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03531.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423684</comments>
            <pubDate>Sat, 19 Nov 2011 13:29:38 +0100</pubDate>
            <guid isPermaLink="false">5423684</guid>        </item>
        <item>
            <title>Termination of refractory focal status epilepticus by the P‐glycoprotein inhibitor verapamil</title>
            <link>http://www.medworm.com/index.php?rid=5423683&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03513.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423683</comments>
            <pubDate>Sat, 19 Nov 2011 13:29:36 +0100</pubDate>
            <guid isPermaLink="false">5423683</guid>        </item>
        <item>
            <title>Genetic prion disease–associated myelodysplasia and SIADH in siblings</title>
            <link>http://www.medworm.com/index.php?rid=5423682&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03511.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423682</comments>
            <pubDate>Sat, 19 Nov 2011 13:29:34 +0100</pubDate>
            <guid isPermaLink="false">5423682</guid>        </item>
        <item>
            <title>Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5423681&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03595.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423681</comments>
            <pubDate>Sat, 19 Nov 2011 13:29:33 +0100</pubDate>
            <guid isPermaLink="false">5423681</guid>        </item>
        <item>
            <title>Corrigendum</title>
            <link>http://www.medworm.com/index.php?rid=5423680&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03566.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423680</comments>
            <pubDate>Sat, 19 Nov 2011 13:29:31 +0100</pubDate>
            <guid isPermaLink="false">5423680</guid>        </item>
        <item>
            <title>Publishing changes and information delivery in the clinical neurosciences</title>
            <link>http://www.medworm.com/index.php?rid=5423679&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03594.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423679</comments>
            <pubDate>Sat, 19 Nov 2011 13:29:08 +0100</pubDate>
            <guid isPermaLink="false">5423679</guid>        </item>
        <item>
            <title>Deep Brain Stimulation in Pantothenate Kinase Associated Neurodegeneration: challenges for the future</title>
            <link>http://www.medworm.com/index.php?rid=5423678&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03585.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423678</comments>
            <pubDate>Sat, 19 Nov 2011 13:26:39 +0100</pubDate>
            <guid isPermaLink="false">5423678</guid>        </item>
        <item>
            <title>Natalizumab discontinuation: an increasingly tricky proposition</title>
            <link>http://www.medworm.com/index.php?rid=5389798&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03574.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389798</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389798</guid>        </item>
        <item>
            <title>Pulse monthly steroids during an elective interruption of natalizumab: a post‐marketing study</title>
            <link>http://www.medworm.com/index.php?rid=5389797&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03577.x</link>
            <description>Conclusions:  Our findings suggest that i.v. steroids are not currently recommendable as drug coverage during a scheduled treatment interruption period. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389797</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389797</guid>        </item>
        <item>
            <title>Glucose metabolism in sporadic Creutzfeldt–Jakob disease: a statistical parametric mapping analysis of 18F‐FDG PET</title>
            <link>http://www.medworm.com/index.php?rid=5389800&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03570.x</link>
            <description>Conclusions:  Glucose hypometabolism in sCJD was detected in extensive cortical regions; however, it was not found in the basal ganglia or thalamus, which are frequently reported to be affected on diffusion‐weighted images. The medial temporal area, which is possibly resistant to the prion deposits, was also less involved in sCJD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389800</comments>
            <pubDate>Fri, 04 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389800</guid>        </item>
        <item>
            <title>Diabetes and previous stroke: hazards for intravenous thrombolysis?</title>
            <link>http://www.medworm.com/index.php?rid=5389799&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03576.x</link>
            <description>Conclusions:  Acute IS diabetic patients with PCI who were treated with IVT had similar outcomes to patients without such history, with no increase in the rates of SICH. Thus, they should not be excluded from IVT only on the basis of DM and PCI. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389799</comments>
            <pubDate>Fri, 04 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389799</guid>        </item>
        <item>
            <title>Assessment of D216H DYT1 polymorphism in a Chinese primary dystonia patient cohort</title>
            <link>http://www.medworm.com/index.php?rid=5389796&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03582.x</link>
            <description>Conclusions:  Our findings do not confirm that the allele contributes to the risk of D216H SNP primary dystonia. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389796</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5389796</guid>        </item>
        <item>
            <title>Evidence‐Based Management of Epilepsy</title>
            <link>http://www.medworm.com/index.php?rid=5365285&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03580.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365285</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365285</guid>        </item>
        <item>
            <title>Conventional brain MRI in neuromyelitis optica</title>
            <link>http://www.medworm.com/index.php?rid=5365291&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03565.x</link>
            <description>Conclusions:  Brain lesions in NMO are a consistent feature of the disease. International consensus MRI criteria are needed for NMO analogous to the existing criteria for MS. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365291</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365291</guid>        </item>
        <item>
            <title>Are there ethnic differences in impulsive/compulsive behaviors in Parkinson’s disease?</title>
            <link>http://www.medworm.com/index.php?rid=5365290&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03571.x</link>
            <description>Conclusions:  The prevalence of ICB is lower in Taiwan as compared with the Caucasians, with similar risk factors. The possible reasons include differences in ethnicity, environmental, cultural, and social factors as well as the dosage and selection of dopaminergic medications. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365290</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365290</guid>        </item>
        <item>
            <title>Functional MRI and motor behavioral changes obtained with constraint‐induced movement therapy in chronic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5365289&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03572.x</link>
            <description>Conclusions:  Alterations in sensorimotor cortical activations (fMRI) and corticospinal conductivity (TMS) were observed after intensive rehabilitation in patients with chronic stroke. Activation and functional changes in fMRI and TMS correlated significantly with the degree of clinical improvement in hand motor behavior. The present data advance the understanding of the functional underpinnings of motor recovery, which may be obtained even years after the stroke. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365289</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365289</guid>        </item>
        <item>
            <title>Editorial comment on the use of botulinum toxin</title>
            <link>http://www.medworm.com/index.php?rid=5365288&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03573.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365288</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365288</guid>        </item>
        <item>
            <title>Characterization of the Asian myopathy patients with VCP mutations</title>
            <link>http://www.medworm.com/index.php?rid=5365287&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03575.x</link>
            <description>Conclusions:  Valosin‐containing protein mutations are not rare in Asian patients, and gene analysis should be considered for patients with adult‐onset rimmed vacuolar myopathy with neurogenic changes. A wide variety of central and peripheral nervous system symptoms coupled with rare bone abnormalities may complicate diagnosis. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365287</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365287</guid>        </item>
        <item>
            <title>Early‐stage cognitive impairment in Parkinson’s disease and the influence of dopamine replacement therapy</title>
            <link>http://www.medworm.com/index.php?rid=5365286&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03578.x</link>
            <description>Conclusion:  Selective impairments in strategy use and the generation of random motor behaviour are a very early feature of PD and might be of predictive value in further frontal cognitive deterioration. Furthermore, DA replacement therapy seems to improve frontal lobe function (strategy use) and worsen temporal lobe function (visual memory). (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365286</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365286</guid>        </item>
        <item>
            <title>The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non‐hemorrhagic infarct, and non‐lesional venous stroke in patients with cerebral sinus–venous thrombosis</title>
            <link>http://www.medworm.com/index.php?rid=5365293&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03562.x</link>
            <description>Conclusion:  Headache, convulsion, behavioral disorder, seizures, and speech disorders were the most frequent clinical symptoms of patients with hemorrhagic CSVT. Specific risk factors, including pregnancy/puerberium, early and extended thrombosis of large sinus, and presence of high blood pressure at admission, are associated with hemorrhagic lesion and unfavorable outcome. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365293</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365293</guid>        </item>
        <item>
            <title>Five‐year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins</title>
            <link>http://www.medworm.com/index.php?rid=5365292&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03559.x</link>
            <description>In 2005, incobotulinumtoxinA (Xeomin®), a new botulinum toxin (BT) type A drug without complexing proteins (CPs), became available. This paper reviews the specific features of Xeomin® and the experience gathered with it during the last 5 years. Compared with conventional BT drugs, Xeomin®’s extended shelf live and its simplified temperature restrictions indicate that CPs are not necessary for BT drug stability. Its reduced molecular size does not translate into diffusion differences, and its potency labelling is identical to that of onabotulinumtoxinA (Botox®). With a reduced content of inactivated botulinum neurotoxin, Xeomin® should have reduced antigenicity. Lack of CP’s may further reduce antigenicity. Xeomin®’s therapeutic efficacy against cervical dystonia, blepharospas...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365292</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5365292</guid>        </item>
        <item>
            <title>An intravenous insulin protocol for strict glycemic control in acute ischaemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5325292&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03537.x</link>
            <description>Conclusions:  The proposed intravenous insulin protocol controls acute post‐stroke hyperglycemia but frequently leads to hypokalemia. This issue needs to be addressed for the protocol to be suitable for use in larger, randomized controlled trial to explore its clinical effect. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5325292</comments>
            <pubDate>Tue, 18 Oct 2011 22:52:59 +0100</pubDate>
            <guid isPermaLink="false">5325292</guid>        </item>
        <item>
            <title>The relationship between self‐reported executive performance and psychological characteristics in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5325293&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03538.x</link>
            <description>Conclusions:  Self‐reports of executive performance are generally reliable, but 29% of patients with MS underestimated or overestimated their abilities. It is especially important to identify underestimators as they display underlying psychological problems and dysfunctional coping styles in need of further psychological treatment. Informants are valuable in this respect, but should not be seen as the ‘gold standard’ to identify cognitive impairment. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5325293</comments>
            <pubDate>Tue, 18 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5325293</guid>        </item>
        <item>
            <title>Evidence‐Based Management of Stroke</title>
            <link>http://www.medworm.com/index.php?rid=5316804&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03567.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316804</comments>
            <pubDate>Sat, 15 Oct 2011 15:05:55 +0100</pubDate>
            <guid isPermaLink="false">5316804</guid>        </item>
        <item>
            <title>Dementia quality of life instrument – construct and concurrent validity in patients with mild to moderate dementia</title>
            <link>http://www.medworm.com/index.php?rid=5316808&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03561.x</link>
            <description>Conclusion:  The DQoL can be used in dementia research for assessing positive and negative affect, feelings of belonging and self‐esteem. The findings suggest further research to improve the structure of the scales aesthetics, feelings of belonging and self‐esteem. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316808</comments>
            <pubDate>Sat, 15 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5316808</guid>        </item>
        <item>
            <title>European neuroborreliosis: neuropsychological findings 30 months post‐treatment</title>
            <link>http://www.medworm.com/index.php?rid=5316807&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03563.x</link>
            <description>Conclusions:  As a group, LNB‐treated patients scored lower on four NP subtasks assessing processing speed, visual and verbal memory, and executive/attention functions, as compared to matched controls. The distribution of NP dysfunctions indicates that most LNB‐treated patients perform comparable to controls, whilst a small subgroup have a debilitating long‐term course with cognitive problems. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316807</comments>
            <pubDate>Sat, 15 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5316807</guid>        </item>
        <item>
            <title>The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5316806&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03564.x</link>
            <description>Conclusions:  This study suggests that a high ferritin level is an important predictor of HT, PH, and sHT in patients with acute ischaemic stroke. Lowering the ferritin level with iron‐modifying agents or using free radical scavengers could be helpful to prevent HT in ischaemic stroke. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316806</comments>
            <pubDate>Sat, 15 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5316806</guid>        </item>
        <item>
            <title>Editorial comment on ‘5 year experience with incobotulinumtoxinA (Xeomin®) the first botulinum toxin drug free of complexing proteins’</title>
            <link>http://www.medworm.com/index.php?rid=5316805&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03560.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316805</comments>
            <pubDate>Sat, 15 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5316805</guid>        </item>
        <item>
            <title>A case of anti‐N‐methyl‐D‐aspartate receptor encephalitis with systemic sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5305859&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03485.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305859</comments>
            <pubDate>Wed, 12 Oct 2011 12:51:09 +0100</pubDate>
            <guid isPermaLink="false">5305859</guid>        </item>
        <item>
            <title>JC virus myelitis without cerebral involvement in acute myeloid leukemia</title>
            <link>http://www.medworm.com/index.php?rid=5305858&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03480.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305858</comments>
            <pubDate>Wed, 12 Oct 2011 12:51:06 +0100</pubDate>
            <guid isPermaLink="false">5305858</guid>        </item>
        <item>
            <title>Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5305857&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03579.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305857</comments>
            <pubDate>Wed, 12 Oct 2011 12:51:04 +0100</pubDate>
            <guid isPermaLink="false">5305857</guid>        </item>
        <item>
            <title>Neurodegenerative Disorders. A Clinical Guide</title>
            <link>http://www.medworm.com/index.php?rid=5305855&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03568.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305855</comments>
            <pubDate>Wed, 12 Oct 2011 12:40:41 +0100</pubDate>
            <guid isPermaLink="false">5305855</guid>        </item>
        <item>
            <title>Artistic productivity and creative thinking in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5305856&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03546.x</link>
            <description>Conclusions:  Our study suggests that newly acquired artistic‐like production in patients with PD is not associated with impulsivity or ICDs. Artistic‐like production might represent the emerging of innate skills in a subset of predisposed patients with PD on dopaminergic therapy. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5305856</comments>
            <pubDate>Mon, 10 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5305856</guid>        </item>
        <item>
            <title>Soluble VEGFR1 (sVEGFR1) as a novel marker of amyotrophic lateral sclerosis (ALS) in the North Indian ALS patients</title>
            <link>http://www.medworm.com/index.php?rid=5298186&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03548.x</link>
            <description>Conclusions:  Soluble vascular endothelial growth factor receptor‐1 downregulation may result in increased serum VEGF‐A reported previously in our patients with ALS and may indicate the activation of compensatory mechanism in response to neurodegeneration. The lower serum sVEGFR1 levels may have a possible clinicopathological association, if not causal, to the extended survival of North Indian patients with ALS; however, the result needs further investigations particularly in comparable Caucasian ALS population. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298186</comments>
            <pubDate>Fri, 07 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5298186</guid>        </item>
        <item>
            <title>Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5298185&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03533.x</link>
            <description>Conclusion:  TCS of the SN and olfactory testing play complementary roles in increasing diagnostic power in PD. As both tests are easy to perform, noninvasive, and inexpensive, the combination of TCS of the SN and olfactory testing may contribute to early and accurate diagnosis of PD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298185</comments>
            <pubDate>Fri, 07 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5298185</guid>        </item>
        <item>
            <title>Recovery after stroke: more than just walking and talking again If you don’t look for it, you won’t find it</title>
            <link>http://www.medworm.com/index.php?rid=5287365&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03520.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287365</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287365</guid>        </item>
        <item>
            <title>Treatment of articulatory dysfunction in Parkinson’s disease using repetitive transcranial magnetic stimulation</title>
            <link>http://www.medworm.com/index.php?rid=5287364&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03524.x</link>
            <description>Conclusion:  The results support the use of high‐frequency rTMS as a therapeutic tool for the treatment of articulatory dysfunction in PD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287364</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287364</guid>        </item>
        <item>
            <title>The prevalence of neuromyelitis optica in South East Wales</title>
            <link>http://www.medworm.com/index.php?rid=5287362&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03529.x</link>
            <description>Conclusion:  This study suggests that NMO and related spectrum disorders are at least as frequent in Northern European populations as in non‐Caucasian populations and that the demographic profile of prevalent patients differs from clinic‐based cohorts. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287362</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287362</guid>        </item>
        <item>
            <title>Move for Change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5287361&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03532.x</link>
            <description>Conclusions:  These data highlight challenges that patients with PD face during the period of diagnosis, despite introduction of the Charter. These findings can assist healthcare professionals and policy makers in improving the level of care for patients and their families across Europe, and we offer suggestions about how this can be achieved. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287361</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287361</guid>        </item>
        <item>
            <title>Fatigue, depression, and health‐related quality of life in patients with multiple sclerosis in Isfahan, Iran</title>
            <link>http://www.medworm.com/index.php?rid=5287360&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03535.x</link>
            <description>Conclusions:  Our findings suggest that MS‐related physical disability, fatigue, and depression affect the HRQoL of MS patients, independently of each other and other potential confounding factors. Effective interventions that target fatigue and depression may help improve the QoL of patients, regardless of their disease type and level of disability. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287360</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287360</guid>        </item>
        <item>
            <title>Inheritance of moyamoya disease in a Caucasian family</title>
            <link>http://www.medworm.com/index.php?rid=5287359&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03536.x</link>
            <description>Conclusions:  This is the first report on a father‐to‐child inheritance pattern in Caucasian patients with idiopathic Moyamoya disease (MMD). Our cases indicate possible genetic risk factors for the genesis of Caucasian Moyamoya disease. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287359</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287359</guid>        </item>
        <item>
            <title>Nocebo in fibromyalgia: meta‐analysis of placebo‐controlled clinical trials and implications for practice</title>
            <link>http://www.medworm.com/index.php?rid=5287358&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03528.x</link>
            <description>Conclusions:  Nocebo is remarkably prevalent in FM patients participating in RCTs. Because nocebo contributes to drug intolerance and treatment failure in clinical practice, identification of predisposing factors and efforts to prevent nocebo by educating these patients appropriately may be important for FM outcome. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287358</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287358</guid>        </item>
        <item>
            <title>Usefulness of pulmonary function tests and blood gases in acute neuromuscular respiratory failure</title>
            <link>http://www.medworm.com/index.php?rid=5287357&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03539.x</link>
            <description>Conclusions:  In patients with primary acute NMRF, bedside PFT and ABG before MV can be used to predict evolution and outcome. Lower MIP and MEP portend prolonged MV and are more useful than forced vital capacity. Presentation with chronic respiratory acidosis is associated with high risk of in‐hospital mortality and severe disability, especially in patients without treatable diagnoses. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287357</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287357</guid>        </item>
        <item>
            <title>Pain in amyotrophic lateral sclerosis: a population‐based controlled study</title>
            <link>http://www.medworm.com/index.php?rid=5287355&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03540.x</link>
            <description>Conclusions:  Our study indicates that pain is frequent in all stages of ALS, but that it often goes underrecognized and undertreated. It is significantly more frequent in patients with ALS than in population‐based controls. Future studies need to clarify the mechanisms of pain in ALS and determine the most effective treatment strategy. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287355</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287355</guid>        </item>
        <item>
            <title>Reassessing received wisdom in ALS – pain is common when studied systematically</title>
            <link>http://www.medworm.com/index.php?rid=5287354&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03541.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287354</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287354</guid>        </item>
        <item>
            <title>Stroke mechanism in patients with non‐valvular atrial fibrillation according to the CHADS2 and CHA2DS2‐VASc scores</title>
            <link>http://www.medworm.com/index.php?rid=5287353&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03547.x</link>
            <description>Conclusions:  Increased frequency of concomitant PCSE and that of the atherothrombotic mechanism may explain the high risk of stroke in patients with higher CHADS2/CHA2DS2‐VASc score. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287353</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287353</guid>        </item>
        <item>
            <title>Clinical outcome of spontaneous non‐aneurysmal subarachnoid hemorrhage in 108 patients</title>
            <link>http://www.medworm.com/index.php?rid=5287352&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03542.x</link>
            <description>Conclusions:  Non‐aneurysmal SAH with a perimesencephalic pattern of bleeding has a benign course and excellent short‐term and long‐term prognosis. Patients with non‐aneurysmal SAH with an aneurysmal pattern of bleeding have more complications, and the initial clinical situation has a significant impact on their prognosis. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287352</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287352</guid>        </item>
        <item>
            <title>Monthly variation of multiple sclerosis activity in the southern hemisphere: analysis from 996 relapses in Brazil</title>
            <link>http://www.medworm.com/index.php?rid=5287351&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03543.x</link>
            <description>Conclusion:  Most exacerbations were in the spring/summer transition, which also showed higher UV radiation index and humidity rate. Along with other environmental factors, seasonal fluctuation contributes to MS activity. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287351</comments>
            <pubDate>Tue, 04 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287351</guid>        </item>
        <item>
            <title>Increased plasma levels of total homocysteine but not asymmetric dimethylarginine in Hispanic subjects with ischemic stroke FREC‐VI sub‐study</title>
            <link>http://www.medworm.com/index.php?rid=5298184&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03534.x</link>
            <description>Conclusions:  In this Hispanic population, with relatively normal renal function, plasma levels of tHcy but not ADMA were associated with stroke independent of other cardiovascular risk factors. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298184</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5298184</guid>        </item>
        <item>
            <title>Pontine‐to‐midbrain ratio indexes ocular‐motor function and illness stage in adult Niemann–Pick disease type C</title>
            <link>http://www.medworm.com/index.php?rid=5287350&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.3545.x</link>
            <description>Conclusions:  Pontine‐to‐midbrain ratio was increased in adult patients with NPC compared to controls, although not to the same degree as previously described in PSP, which also presents with significant gaze palsy. These changes were driven predominantly by progressive midbrain atrophy. The strong correlation with illness and ocular‐motor variables suggests that it may be a useful marker for illness progression in NPC. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287350</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5287350</guid>        </item>
        <item>
            <title>Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage</title>
            <link>http://www.medworm.com/index.php?rid=5262502&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03523.x</link>
            <description>Conclusion:  Early infarction after surgical aneurysm occlusion seems to have different risk factors and worse prognosis than late infarct which is mostly associated with delayed cerebral ischaemia. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262502</comments>
            <pubDate>Thu, 29 Sep 2011 13:40:22 +0100</pubDate>
            <guid isPermaLink="false">5262502</guid>        </item>
        <item>
            <title>Association study of functional polymorphisms in serotonin transporter gene with temporal lobe epilepsy in Han Chinese population</title>
            <link>http://www.medworm.com/index.php?rid=5262504&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03521.x</link>
            <description>Conclusion:  Our study suggested 10‐repeat allele of 5‐HTTVNTR may be associated with TLE susceptibility. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262504</comments>
            <pubDate>Tue, 27 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5262504</guid>        </item>
        <item>
            <title>Significance of microbleeds in patients with transient ischaemic attack</title>
            <link>http://www.medworm.com/index.php?rid=5262503&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03522.x</link>
            <description>Conclusion:  Microbleeds alone or in combination with acute ischaemic lesions may increase the risk for subsequent ischaemic stroke after TIA within 3 months. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262503</comments>
            <pubDate>Tue, 27 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5262503</guid>        </item>
        <item>
            <title>No increase in headache after previous intracranial infections: a historical cohort study (HUNT)</title>
            <link>http://www.medworm.com/index.php?rid=5262508&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03525.x</link>
            <description>Conclusions:  This study challenges the existence of chronic post‐bacterial meningitis headache and does not indicate the presence of other long‐term headaches induced by intracranial infection. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262508</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5262508</guid>        </item>
        <item>
            <title>Radiopacity of intracerebral hemorrhage correlates with perihemorrhagic edema</title>
            <link>http://www.medworm.com/index.php?rid=5262507&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03526.x</link>
            <description>Conclusions:  Higher ICH radiopacity, reflecting higher in vivo hematoma iron content, is associated with more PHE after ICH. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262507</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5262507</guid>        </item>
        <item>
            <title>Expression of stromal‐cell‐derived factor‐1 (SDF‐1): a predictor of ischaemic stroke?</title>
            <link>http://www.medworm.com/index.php?rid=5262506&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03527.x</link>
            <description>Conclusions:  Platelet SDF‐1 surface expression did not show any significant difference in patients with TIA and ischaemic stroke compared with patients with NI events. Thus, single biomarker evaluation of platelet SDF‐1 surface expression is not helpful to predict ischaemic stroke. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262506</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5262506</guid>        </item>
        <item>
            <title>Use of a handheld, computerized device as a decision support tool for stroke classification</title>
            <link>http://www.medworm.com/index.php?rid=5262505&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03530.x</link>
            <description>Conclusions:  The stroke classification tool using a handheld, computerized device was easy, accurate, and reliable over the conventional method. It may have additional benefit because a handheld, computerized device is accessible anytime and anywhere. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262505</comments>
            <pubDate>Mon, 26 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5262505</guid>        </item>
        <item>
            <title>UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?</title>
            <link>http://www.medworm.com/index.php?rid=5252048&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03500.x</link>
            <description>Conclusions:  Most health research funding in the UK is currently directed towards cancer. When compared to their burden, our analysis suggests that research spending on dementia and stroke is severely underfunded in comparison with cancer and CHD. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5252048</comments>
            <pubDate>Mon, 26 Sep 2011 01:02:28 +0100</pubDate>
            <guid isPermaLink="false">5252048</guid>        </item>
        <item>
            <title>Chorea associated with vitamin B12 deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5228023&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03478.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228023</comments>
            <pubDate>Mon, 19 Sep 2011 04:37:12 +0100</pubDate>
            <guid isPermaLink="false">5228023</guid>        </item>
        <item>
            <title>LRRK2 mutations are uncommon in Turkey</title>
            <link>http://www.medworm.com/index.php?rid=5228022&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03471.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228022</comments>
            <pubDate>Mon, 19 Sep 2011 04:37:10 +0100</pubDate>
            <guid isPermaLink="false">5228022</guid>        </item>
        <item>
            <title>Highly task‐specific oromandibular dystonia in a telephone operator</title>
            <link>http://www.medworm.com/index.php?rid=5228021&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03468.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228021</comments>
            <pubDate>Mon, 19 Sep 2011 04:37:08 +0100</pubDate>
            <guid isPermaLink="false">5228021</guid>        </item>
        <item>
            <title>Cerebral vasoreactivity in white coat hypertension – response to comments written by V.K. Sharma and A.K. Sinha</title>
            <link>http://www.medworm.com/index.php?rid=5228020&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03483.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228020</comments>
            <pubDate>Mon, 19 Sep 2011 04:37:07 +0100</pubDate>
            <guid isPermaLink="false">5228020</guid>        </item>
        <item>
            <title>Cerebral vasoreactivity in white coat hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5228019&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03482.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228019</comments>
            <pubDate>Mon, 19 Sep 2011 04:37:05 +0100</pubDate>
            <guid isPermaLink="false">5228019</guid>        </item>
        <item>
            <title>Calendar</title>
            <link>http://www.medworm.com/index.php?rid=5228018&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03544.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228018</comments>
            <pubDate>Mon, 19 Sep 2011 04:37:01 +0100</pubDate>
            <guid isPermaLink="false">5228018</guid>        </item>
        <item>
            <title>Early neurological outcomes according to CHADS2 score in stroke patients with non‐valvular atrial fibrillation</title>
            <link>http://www.medworm.com/index.php?rid=5228012&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03518.x</link>
            <description>Conclusions:  Our data indicate that patients with NVAF and higher CHADS2 score or CHA2DS2‐VASc score are more likely to develop severe stroke and a worse clinical course is expected in these patients after stroke presentation. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228012</comments>
            <pubDate>Mon, 19 Sep 2011 04:34:24 +0100</pubDate>
            <guid isPermaLink="false">5228012</guid>        </item>
        <item>
            <title>Is there underfunding in brain research? The UK research expenditure</title>
            <link>http://www.medworm.com/index.php?rid=5228017&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03499.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228017</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228017</guid>        </item>
        <item>
            <title>EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force</title>
            <link>http://www.medworm.com/index.php?rid=5228016&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03501.x</link>
            <description>Background:  The evidence base for the diagnosis and management of amyotrophic lateral sclerosis (ALS) is weak.Objectives:  To provide evidence‐based or expert recommendations for the diagnosis and management of ALS based on a literature search and the consensus of an expert panel.Methods:  All available medical reference systems were searched, and original papers, meta‐analyses, review papers, book chapters and guidelines recommendations were reviewed. The final literature search was performed in February 2011. Recommendations were reached by consensus.Recommendations:  Patients with symptoms suggestive of ALS should be assessed as soon as possible by an experienced neurologist. Early diagnosis should be pursued, and investigations, including neurophysiology, performed with a ...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228016</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228016</guid>        </item>
        <item>
            <title>Routine cardiac evaluation in patients with ischaemic stroke and absence of known atrial fibrillation or coronary heart disease: transthoracic echocardiography vs. multidetector cardiac computed tomography</title>
            <link>http://www.medworm.com/index.php?rid=5228015&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03505.x</link>
            <description>Conclusion:  Multidetector cardiac computed tomography proved to be complementary to TTE for the identification of CSCE and can detect asymptomatic CAD, one of the major causes of vascular death in patients with stroke, in patients with non‐atrial fibrillation‐related stroke. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228015</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228015</guid>        </item>
        <item>
            <title>tPA for stroke – Are we ready to remove the barriers?</title>
            <link>http://www.medworm.com/index.php?rid=5228014&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03515.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228014</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228014</guid>        </item>
        <item>
            <title>Improving the diagnosis and prognosis of atrial fibrillation in stroke: quo vadis?</title>
            <link>http://www.medworm.com/index.php?rid=5228013&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03516.x</link>
            <description>(Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228013</comments>
            <pubDate>Wed, 14 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5228013</guid>        </item>
        <item>
            <title>Nystagmus and oscillopsia</title>
            <link>http://www.medworm.com/index.php?rid=5211037&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03503.x</link>
            <description>The ocular motor system consists of several subsystems, including the vestibular ocular nystagmus saccade system, the pursuit system, the fixation and gaze‐holding system and the vergence system. All these subsystems aid the stabilization of the images on the retina during eye and head movements and any kind of disturbance of one of the systems can cause instability of the eyes (e.g. nystagmus) or an inadequate eye movement causing a mismatch between head and eye movement (e.g. bilateral vestibular failure). In both situations, the subjects experience a movement of the world (oscillopsia) which is quite disturbing. New insights into the patho‐physiology of some of the ocular motor disorders have helped to establish new treatment options, in particular in downbeat nystagmus, upbeat nyst...</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211037</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5211037</guid>        </item>
        <item>
            <title>A single‐arm, open‐label study of alemtuzumab in treatment‐refractory patients with multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5211038&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03507.x</link>
            <description>Conclusions:  Alemtuzumab effectively reduced relapse rates and improved clinical scores in patients with active relapsing‐remitting multiple sclerosis not controlled by interferon therapy. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5211038</comments>
            <pubDate>Wed, 07 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5211038</guid>        </item>
        <item>
            <title>MRI‐based intravenous thrombolysis in stroke patients with unknown time of symptom onset</title>
            <link>http://www.medworm.com/index.php?rid=5197532&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03504.x</link>
            <description>Conclusions:  Thrombolysis after MRI seems safe and effective in UTOS. This observation may encourage those who plan prospective placebo‐controlled trials of thrombolytics in this subgroup of stroke patients. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5197532</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5197532</guid>        </item>
        <item>
            <title>Apathy in acute stroke patients</title>
            <link>http://www.medworm.com/index.php?rid=5197531&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03508.x</link>
            <description>Conclusion:  Apathy was frequent in acute stroke patients, and it was predicted by acute intracerebral haemorrhage and right hemispherical acute stroke lesion. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5197531</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5197531</guid>        </item>
        <item>
            <title>Clinical and molecular genetic factors affecting postoperative seizure control of 183 Chinese adult patients with low‐grade gliomas</title>
            <link>http://www.medworm.com/index.php?rid=5197530&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03509.x</link>
            <description>Conclusions:  Gross total resection of the tumor, LOH 19q and low Ki‐67 expression were associated with favorable seizure control after surgery for the patients with LGGs. The possible involvement of other factors should be investigated further. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5197530</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5197530</guid>        </item>
        <item>
            <title>The role of intima‐media‐thickness, ankle‐brachial‐index and inflammatory biochemical parameters for stroke risk prediction: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5197529&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03510.x</link>
            <description>Conclusions:  Based on the data presented, there is clear evidence that measurement of the ankle‐brachial index identifies subjects of increased stroke risk in primary and secondary care settings as well as of stroke recurrence in acute stroke. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5197529</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5197529</guid>        </item>
        <item>
            <title>Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5197528&amp;cid=s_32226_25_f&amp;fid=32226&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1468-1331.2011.03512.x</link>
            <description>Conclusions:  This study provides the first objectively measured evidence that adjunct rasagiline 1 mg/day is effective in reducing the severity of motor symptoms in the OFF state. This suggests a continuous effect of rasagiline 1 mg/day throughout the day and night and is consistent with its extended duration of therapeutic action. (Source: European Journal of Neurology)</description>
            <author>European Journal of Neurology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5197528</comments>
            <pubDate>Mon, 05 Sep 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5197528</guid>        </item>
    </channel>
</rss>

